APO Research
Talk to an analyst

APO RESEARCH · REPORT

Disulfiramab Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Disulfiramab Injection Market Analysis and Forecast 2026-2032

30 December 2025195 pages

Choose your research edition.

Industry ResearchDisulfiramab Injection Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Disulfiramab Injection Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Disulfiramab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Disulfiramab Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Disulfiramab Injection Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Disulfiramab Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Disulfiramab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Disulfiramab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Disulfiramab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Disulfiramab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Disulfiramab Injection include Amgen Inc., BeiGene, Boan Biotech and Luye Pharma Gr, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Disulfiramab Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Disulfiramab Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Disulfiramab Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Disulfiramab Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Disulfiramab Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Disulfiramab Injection sales, projected growth trends, production technology, application and end-user industry.

Disulfiramab Injection Segment by Company

Amgen Inc.

BeiGene

Boan Biotech

Luye Pharma Gr

Disulfiramab Injection Segment by Type

Adults

Minors

Disulfiramab Injection Segment by Application

Clinical

Research Institute

Disulfiramab Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Disulfiramab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Disulfiramab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Disulfiramab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Disulfiramab Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Disulfiramab Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Disulfiramab Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Disulfiramab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Adults Major Manufacturers Table 3. Minors Major Manufacturers Table 4. Global Disulfiramab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinical Major Manufacturers Table 6. Research Institute Major Manufacturers Table 7. Disulfiramab Injection Industry Trends Table 8. Disulfiramab Injection Industry Drivers Table 9. Disulfiramab Injection Industry Opportunities and Challenges Table 10. Disulfiramab Injection Industry Restraints Table 11. Global Disulfiramab Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Disulfiramab Injection Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Disulfiramab Injection Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Disulfiramab Injection Revenue Market Share by Region (2021-2026) Table 15. Global Disulfiramab Injection Revenue Market Share by Region (2027-2032) Table 16. Global Disulfiramab Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 17. Global Disulfiramab Injection Sales by Region (2021-2026) & (Kg) Table 18. Global Disulfiramab Injection Sales by Region (2027-2032) & (Kg) Table 19. Global Disulfiramab Injection Sales Market Share by Region (2021-2026) Table 20. Global Disulfiramab Injection Sales Market Share by Region (2027-2032) Table 21. Global Disulfiramab Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Disulfiramab Injection Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Disulfiramab Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Disulfiramab Injection Sales Market Share by Manufacturers (2021-2026) Table 25. Global Disulfiramab Injection Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 26. Global Disulfiramab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Disulfiramab Injection Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Disulfiramab Injection Manufacturers, Product Type & Application Table 29. Global Disulfiramab Injection Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Disulfiramab Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Disulfiramab Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Disulfiramab Injection Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Disulfiramab Injection Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Disulfiramab Injection Revenue Market Share by Type (2021-2026) Table 36. Global Disulfiramab Injection Revenue Market Share by Type (2027-2032) Table 37. Global Disulfiramab Injection Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 38. Global Disulfiramab Injection Sales by Type (2021-2026) & (Kg) Table 39. Global Disulfiramab Injection Sales by Type (2027-2032) & (Kg) Table 40. Global Disulfiramab Injection Sales Market Share by Type (2021-2026) Table 41. Global Disulfiramab Injection Sales Market Share by Type (2027-2032) Table 42. Global Disulfiramab Injection Price by Type (2021-2026) & (US$/Kg) Table 43. Global Disulfiramab Injection Price by Type (2027-2032) & (US$/Kg) Table 44. Global Disulfiramab Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Disulfiramab Injection Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Disulfiramab Injection Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Disulfiramab Injection Revenue Market Share by Application (2021-2026) Table 48. Global Disulfiramab Injection Revenue Market Share by Application (2027-2032) Table 49. Global Disulfiramab Injection Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 50. Global Disulfiramab Injection Sales by Application (2021-2026) & (Kg) Table 51. Global Disulfiramab Injection Sales by Application (2027-2032) & (Kg) Table 52. Global Disulfiramab Injection Sales Market Share by Application (2021-2026) Table 53. Global Disulfiramab Injection Sales Market Share by Application (2027-2032) Table 54. Global Disulfiramab Injection Price by Application (2021-2026) & (US$/Kg) Table 55. Global Disulfiramab Injection Price by Application (2027-2032) & (US$/Kg) Table 56. Amgen Inc. Company Information Table 57. Amgen Inc. Business Overview Table 58. Amgen Inc. Disulfiramab Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 59. Amgen Inc. Disulfiramab Injection Product Portfolio Table 60. Amgen Inc. Recent Development Table 61. BeiGene Company Information Table 62. BeiGene Business Overview Table 63. BeiGene Disulfiramab Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 64. BeiGene Disulfiramab Injection Product Portfolio Table 65. BeiGene Recent Development Table 66. Boan Biotech Company Information Table 67. Boan Biotech Business Overview Table 68. Boan Biotech Disulfiramab Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 69. Boan Biotech Disulfiramab Injection Product Portfolio Table 70. Boan Biotech Recent Development Table 71. Luye Pharma Gr Company Information Table 72. Luye Pharma Gr Business Overview Table 73. Luye Pharma Gr Disulfiramab Injection Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Luye Pharma Gr Disulfiramab Injection Product Portfolio Table 75. Luye Pharma Gr Recent Development Table 76. North America Disulfiramab Injection Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Disulfiramab Injection Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Disulfiramab Injection Sales by Type (2021-2026) & (Kg) Table 79. North America Disulfiramab Injection Sales by Type (2027-2032) & (Kg) Table 80. North America Disulfiramab Injection Sales Price by Type (2021-2026) & (US$/Kg) Table 81. North America Disulfiramab Injection Sales Price by Type (2027-2032) & (US$/Kg) Table 82. North America Disulfiramab Injection Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Disulfiramab Injection Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Disulfiramab Injection Sales by Application (2021-2026) & (Kg) Table 85. North America Disulfiramab Injection Sales by Application (2027-2032) & (Kg) Table 86. North America Disulfiramab Injection Sales Price by Application (2021-2026) & (US$/Kg) Table 87. North America Disulfiramab Injection Sales Price by Application (2027-2032) & (US$/Kg) Table 88. North America Disulfiramab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Disulfiramab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 90. North America Disulfiramab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 91. North America Disulfiramab Injection Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 92. North America Disulfiramab Injection Sales by Country (2021-2026) & (Kg) Table 93. North America Disulfiramab Injection Sales by Country (2027-2032) & (Kg) Table 94. North America Disulfiramab Injection Sales Price by Country (2021-2026) & (US$/Kg) Table 95. North America Disulfiramab Injection Sales Price by Country (2027-2032) & (US$/Kg) Table 96. United States Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 97. Canada Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 98. Europe Disulfiramab Injection Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Disulfiramab Injection Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Disulfiramab Injection Sales by Type (2021-2026) & (Kg) Table 101. Europe Disulfiramab Injection Sales by Type (2027-2032) & (Kg) Table 102. Europe Disulfiramab Injection Sales Price by Type (2021-2026) & (US$/Kg) Table 103. Europe Disulfiramab Injection Sales Price by Type (2027-2032) & (US$/Kg) Table 104. Europe Disulfiramab Injection Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Disulfiramab Injection Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Disulfiramab Injection Sales by Application (2021-2026) & (Kg) Table 107. Europe Disulfiramab Injection Sales by Application (2027-2032) & (Kg) Table 108. Europe Disulfiramab Injection Sales Price by Application (2021-2026) & (US$/Kg) Table 109. Europe Disulfiramab Injection Sales Price by Application (2027-2032) & (US$/Kg) Table 110. Europe Disulfiramab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Disulfiramab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. Europe Disulfiramab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. Europe Disulfiramab Injection Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 114. Europe Disulfiramab Injection Sales by Country (2021-2026) & (Kg) Table 115. Europe Disulfiramab Injection Sales by Country (2027-2032) & (Kg) Table 116. Europe Disulfiramab Injection Sales Price by Country (2021-2026) & (US$/Kg) Table 117. Europe Disulfiramab Injection Sales Price by Country (2027-2032) & (US$/Kg) Table 118. Germany Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 119. France Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 120. U.K. Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 121. Italy Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 122. Netherlands Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 123. China Disulfiramab Injection Revenue by Type (2021-2026) & (US$ Million) Table 124. China Disulfiramab Injection Revenue by Type (2027-2032) & (US$ Million) Table 125. China Disulfiramab Injection Sales by Type (2021-2026) & (Kg) Table 126. China Disulfiramab Injection Sales by Type (2027-2032) & (Kg) Table 127. China Disulfiramab Injection Sales Price by Type (2021-2026) & (US$/Kg) Table 128. China Disulfiramab Injection Sales Price by Type (2027-2032) & (US$/Kg) Table 129. China Disulfiramab Injection Revenue by Application (2021-2026) & (US$ Million) Table 130. China Disulfiramab Injection Revenue by Application (2027-2032) & (US$ Million) Table 131. China Disulfiramab Injection Sales by Application (2021-2026) & (Kg) Table 132. China Disulfiramab Injection Sales by Application (2027-2032) & (Kg) Table 133. China Disulfiramab Injection Sales Price by Application (2021-2026) & (US$/Kg) Table 134. China Disulfiramab Injection Sales Price by Application (2027-2032) & (US$/Kg) Table 135. Asia Disulfiramab Injection Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia Disulfiramab Injection Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia Disulfiramab Injection Sales by Type (2021-2026) & (Kg) Table 138. Asia Disulfiramab Injection Sales by Type (2027-2032) & (Kg) Table 139. Asia Disulfiramab Injection Sales Price by Type (2021-2026) & (US$/Kg) Table 140. Asia Disulfiramab Injection Sales Price by Type (2027-2032) & (US$/Kg) Table 141. Asia Disulfiramab Injection Revenue by Application (2021-2026) & (US$ Million) Table 142. Asia Disulfiramab Injection Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia Disulfiramab Injection Sales by Application (2021-2026) & (Kg) Table 144. Asia Disulfiramab Injection Sales by Application (2027-2032) & (Kg) Table 145. Asia Disulfiramab Injection Sales Price by Application (2021-2026) & (US$/Kg) Table 146. Asia Disulfiramab Injection Sales Price by Application (2027-2032) & (US$/Kg) Table 147. Asia Disulfiramab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia Disulfiramab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Asia Disulfiramab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Asia Disulfiramab Injection Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 151. Asia Disulfiramab Injection Sales by Country (2021-2026) & (Kg) Table 152. Asia Disulfiramab Injection Sales by Country (2027-2032) & (Kg) Table 153. Asia Disulfiramab Injection Sales Price by Country (2021-2026) & (US$/Kg) Table 154. Asia Disulfiramab Injection Sales Price by Country (2027-2032) & (US$/Kg) Table 155. Japan Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 156. South Korea Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 157. India Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 158. Australia Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 159. China Taiwan Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 160. Southeast Asia Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 161. SAMEA Disulfiramab Injection Revenue by Type (2021-2026) & (US$ Million) Table 162. SAMEA Disulfiramab Injection Revenue by Type (2027-2032) & (US$ Million) Table 163. SAMEA Disulfiramab Injection Sales by Type (2021-2026) & (Kg) Table 164. SAMEA Disulfiramab Injection Sales by Type (2027-2032) & (Kg) Table 165. SAMEA Disulfiramab Injection Sales Price by Type (2021-2026) & (US$/Kg) Table 166. SAMEA Disulfiramab Injection Sales Price by Type (2027-2032) & (US$/Kg) Table 167. SAMEA Disulfiramab Injection Revenue by Application (2021-2026) & (US$ Million) Table 168. SAMEA Disulfiramab Injection Revenue by Application (2027-2032) & (US$ Million) Table 169. SAMEA Disulfiramab Injection Sales by Application (2021-2026) & (Kg) Table 170. SAMEA Disulfiramab Injection Sales by Application (2027-2032) & (Kg) Table 171. SAMEA Disulfiramab Injection Sales Price by Application (2021-2026) & (US$/Kg) Table 172. SAMEA Disulfiramab Injection Sales Price by Application (2027-2032) & (US$/Kg) Table 173. SAMEA Disulfiramab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. SAMEA Disulfiramab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. SAMEA Disulfiramab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. SAMEA Disulfiramab Injection Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 177. SAMEA Disulfiramab Injection Sales by Country (2021-2026) & (Kg) Table 178. SAMEA Disulfiramab Injection Sales by Country (2027-2032) & (Kg) Table 179. SAMEA Disulfiramab Injection Sales Price by Country (2021-2026) & (US$/Kg) Table 180. SAMEA Disulfiramab Injection Sales Price by Country (2027-2032) & (US$/Kg) Table 181. Brazil Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 182. Argentina Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 183. Chile Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 184. Colombia Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 185. Peru Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 186. Saudi Arabia Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 187. Israel Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 188. UAE Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 189. Turkey Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 190. Iran Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 191. Egypt Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Disulfiramab Injection Distributors List Table 195. Disulfiramab Injection Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Disulfiramab Injection Image Figure 2. Global Disulfiramab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Disulfiramab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. Adults Image Figure 5. Minors Image Figure 6. Global Disulfiramab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Disulfiramab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinical Image Figure 9. Research Institute Image Figure 10. Global Disulfiramab Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Disulfiramab Injection Revenue (2021-2032) & (US$ Million) Figure 12. Global Disulfiramab Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Disulfiramab Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Disulfiramab Injection Revenue Market Share by Region (2021-2032) Figure 15. Global Disulfiramab Injection Sales (2021-2032) & (Kg) Figure 16. Global Disulfiramab Injection Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 17. Global Disulfiramab Injection Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Disulfiramab Injection Sales YoY (2021-2032) & (Kg) Figure 19. Europe Disulfiramab Injection Sales YoY (2021-2032) & (Kg) Figure 20. China Disulfiramab Injection Sales YoY (2021-2032) & (Kg) Figure 21. Asia (Excluding China) Disulfiramab Injection Sales YoY (2021-2032) & (Kg) Figure 22. South America, Middle East and Africa Disulfiramab Injection Sales YoY (2021-2032) & (Kg) Figure 23. Global Disulfiramab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Disulfiramab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Disulfiramab Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Disulfiramab Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Disulfiramab Injection Revenue Market Share by Type (2021-2032) Figure 29. Global Disulfiramab Injection Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 30. Global Disulfiramab Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Disulfiramab Injection Sales Market Share by Type (2021-2032) Figure 32. Global Disulfiramab Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Disulfiramab Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Disulfiramab Injection Revenue Market Share by Application (2021-2032) Figure 35. Global Disulfiramab Injection Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 36. Global Disulfiramab Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Disulfiramab Injection Sales Market Share by Application (2021-2032) Figure 38. North America Disulfiramab Injection Revenue Share by Type (2021-2032) Figure 39. North America Disulfiramab Injection Sales Share by Type (2021-2032) Figure 40. North America Disulfiramab Injection Revenue Share by Application (2021-2032) Figure 41. North America Disulfiramab Injection Sales Share by Application (2021-2032) Figure 42. North America Disulfiramab Injection Revenue Share by Country (2021-2032) Figure 43. North America Disulfiramab Injection Sales Share by Country (2021-2032) Figure 44. Europe Disulfiramab Injection Revenue Share by Type (2021-2032) Figure 45. Europe Disulfiramab Injection Sales Share by Type (2021-2032) Figure 46. Europe Disulfiramab Injection Revenue Share by Application (2021-2032) Figure 47. Europe Disulfiramab Injection Sales Share by Application (2021-2032) Figure 48. Europe Disulfiramab Injection Revenue Share by Country (2021-2032) Figure 49. Europe Disulfiramab Injection Sales Share by Country (2021-2032) Figure 50. China Disulfiramab Injection Revenue Share by Type (2021-2032) Figure 51. China Disulfiramab Injection Sales Share by Type (2021-2032) Figure 52. China Disulfiramab Injection Revenue Share by Application (2021-2032) Figure 53. China Disulfiramab Injection Sales Share by Application (2021-2032) Figure 54. Asia Disulfiramab Injection Revenue Share by Type (2021-2032) Figure 55. Asia Disulfiramab Injection Sales Share by Type (2021-2032) Figure 56. Asia Disulfiramab Injection Revenue Share by Application (2021-2032) Figure 57. Asia Disulfiramab Injection Sales Share by Application (2021-2032) Figure 58. Asia Disulfiramab Injection Revenue Share by Country (2021-2032) Figure 59. Asia Disulfiramab Injection Sales Share by Country (2021-2032) Figure 60. SAMEA Disulfiramab Injection Revenue Share by Type (2021-2032) Figure 61. SAMEA Disulfiramab Injection Sales Share by Type (2021-2032) Figure 62. SAMEA Disulfiramab Injection Revenue Share by Application (2021-2032) Figure 63. SAMEA Disulfiramab Injection Sales Share by Application (2021-2032) Figure 64. SAMEA Disulfiramab Injection Revenue Share by Country (2021-2032) Figure 65. SAMEA Disulfiramab Injection Sales Share by Country (2021-2032) Figure 66. Disulfiramab Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Disulfiramab Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Adults
  • Minors
Applications
  • Clinical
  • Research Institute
Companies covered
  • Amgen Inc.
  • BeiGene
  • Boan Biotech
  • Luye Pharma Gr

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Disulfiramab Injection Market by Type
  3. 1.2.1 Global Disulfiramab Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Adults
  5. 1.2.3 Minors
  6. 1.3 Disulfiramab Injection Market by Application
  7. 1.3.1 Global Disulfiramab Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinical
  9. 1.3.3 Research Institute
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Disulfiramab Injection Market Dynamics
  1. 2.1 Disulfiramab Injection Industry Trends
  2. 2.2 Disulfiramab Injection Industry Drivers
  3. 2.3 Disulfiramab Injection Industry Opportunities and Challenges
  4. 2.4 Disulfiramab Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Disulfiramab Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Disulfiramab Injection Revenue by Region
  3. 3.2.1 Global Disulfiramab Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Disulfiramab Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Disulfiramab Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Disulfiramab Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Disulfiramab Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Disulfiramab Injection Sales by Region
  9. 3.4.1 Global Disulfiramab Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Disulfiramab Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Disulfiramab Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Disulfiramab Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Disulfiramab Injection Revenue by Manufacturers
  2. 4.1.1 Global Disulfiramab Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Disulfiramab Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Disulfiramab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Disulfiramab Injection Sales by Manufacturers
  6. 4.2.1 Global Disulfiramab Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Disulfiramab Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Disulfiramab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Disulfiramab Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Disulfiramab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Disulfiramab Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Disulfiramab Injection Manufacturers, Product Type & Application
  13. 4.7 Global Disulfiramab Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Disulfiramab Injection Market CR5 and HHI
  16. 4.8.2 2025 Disulfiramab Injection Tier 1, Tier 2, and Tier 3
5 Disulfiramab Injection Market by Type
  1. 5.1 Global Disulfiramab Injection Revenue by Type
  2. 5.1.1 Global Disulfiramab Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Disulfiramab Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Disulfiramab Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Disulfiramab Injection Sales by Type
  6. 5.2.1 Global Disulfiramab Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Disulfiramab Injection Sales by Type (2021-2032) & (Kg)
  8. 5.2.3 Global Disulfiramab Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Disulfiramab Injection Price by Type
6 Disulfiramab Injection Market by Application
  1. 6.1 Global Disulfiramab Injection Revenue by Application
  2. 6.1.1 Global Disulfiramab Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Disulfiramab Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Disulfiramab Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Disulfiramab Injection Sales by Application
  6. 6.2.1 Global Disulfiramab Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Disulfiramab Injection Sales by Application (2021-2032) & (Kg)
  8. 6.2.3 Global Disulfiramab Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Disulfiramab Injection Price by Application
7 Company Profiles
  1. 7.1 Amgen Inc.
  2. 7.1.1 Amgen Inc. Company Information
  3. 7.1.2 Amgen Inc. Business Overview
  4. 7.1.3 Amgen Inc. Disulfiramab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Amgen Inc. Disulfiramab Injection Product Portfolio
  6. 7.1.5 Amgen Inc. Recent Developments
  7. 7.2 BeiGene
  8. 7.2.1 BeiGene Company Information
  9. 7.2.2 BeiGene Business Overview
  10. 7.2.3 BeiGene Disulfiramab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 BeiGene Disulfiramab Injection Product Portfolio
  12. 7.2.5 BeiGene Recent Developments
  13. 7.3 Boan Biotech
  14. 7.3.1 Boan Biotech Company Information
  15. 7.3.2 Boan Biotech Business Overview
  16. 7.3.3 Boan Biotech Disulfiramab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Boan Biotech Disulfiramab Injection Product Portfolio
  18. 7.3.5 Boan Biotech Recent Developments
  19. 7.4 Luye Pharma Gr
  20. 7.4.1 Luye Pharma Gr Company Information
  21. 7.4.2 Luye Pharma Gr Business Overview
  22. 7.4.3 Luye Pharma Gr Disulfiramab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Luye Pharma Gr Disulfiramab Injection Product Portfolio
  24. 7.4.5 Luye Pharma Gr Recent Developments
8 North America
  1. 8.1 North America Disulfiramab Injection Market Size by Type
  2. 8.1.1 North America Disulfiramab Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Disulfiramab Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Disulfiramab Injection Price by Type (2021-2032)
  5. 8.2 North America Disulfiramab Injection Market Size by Application
  6. 8.2.1 North America Disulfiramab Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Disulfiramab Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Disulfiramab Injection Price by Application (2021-2032)
  9. 8.3 North America Disulfiramab Injection Market Size by Country
  10. 8.3.1 North America Disulfiramab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Disulfiramab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Disulfiramab Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Disulfiramab Injection Market Size by Type
  2. 9.1.1 Europe Disulfiramab Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Disulfiramab Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Disulfiramab Injection Price by Type (2021-2032)
  5. 9.2 Europe Disulfiramab Injection Market Size by Application
  6. 9.2.1 Europe Disulfiramab Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Disulfiramab Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Disulfiramab Injection Price by Application (2021-2032)
  9. 9.3 Europe Disulfiramab Injection Market Size by Country
  10. 9.3.1 Europe Disulfiramab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Disulfiramab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Disulfiramab Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Disulfiramab Injection Market Size by Type
  2. 10.1.1 China Disulfiramab Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Disulfiramab Injection Sales by Type (2021-2032)
  4. 10.1.3 China Disulfiramab Injection Price by Type (2021-2032)
  5. 10.2 China Disulfiramab Injection Market Size by Application
  6. 10.2.1 China Disulfiramab Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Disulfiramab Injection Sales by Application (2021-2032)
  8. 10.2.3 China Disulfiramab Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Disulfiramab Injection Market Size by Type
  2. 11.1.1 Asia Disulfiramab Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Disulfiramab Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Disulfiramab Injection Price by Type (2021-2032)
  5. 11.2 Asia Disulfiramab Injection Market Size by Application
  6. 11.2.1 Asia Disulfiramab Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Disulfiramab Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Disulfiramab Injection Price by Application (2021-2032)
  9. 11.3 Asia Disulfiramab Injection Market Size by Country
  10. 11.3.1 Asia Disulfiramab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Disulfiramab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Disulfiramab Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Disulfiramab Injection Market Size by Type
  2. 12.1.1 SAMEA Disulfiramab Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Disulfiramab Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Disulfiramab Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Disulfiramab Injection Market Size by Application
  6. 12.2.1 SAMEA Disulfiramab Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Disulfiramab Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Disulfiramab Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Disulfiramab Injection Market Size by Country
  10. 12.3.1 SAMEA Disulfiramab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Disulfiramab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Disulfiramab Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Disulfiramab Injection Value Chain Analysis
  2. 13.1.1 Disulfiramab Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Disulfiramab Injection Production Mode & Process
  6. 13.2 Disulfiramab Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Disulfiramab Injection Distributors
  9. 13.2.3 Disulfiramab Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst